illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Hofseth BioCare
Company logo

Hofseth BioCare | Sustainability Performance

https://www.hofsethbiocare.com
Linkedin

This company is involved in the production of health and nutrition products derived from seafood. Their focus includes developing sustainable and innovative solutions to enhance dietary supplements and functional foods.

2009

Norway

201 - 500 employees

Biotechnology

$10M - 25M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#4853
Overall
#88
in Norway
#64
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Digital emissions
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Navamedic

Norway, Hospital & Health Care, Pharmaceuticals


Company logo
ArcticZymes Technologies

Norway, Hospital & Health Care, Biotechnology


Company logo
BerGenBio

Norway, Hospital & Health Care, Biotechnology

Market cap

5.7B $, 2026▼37% YoY

Revenue

24.6M $, 2025▼0.4% YoY

R&D intensity

4.69% 2025

Digital Emissions


CO2e per visit (g)

Industry benchmark

B/M 0.26 g
1.76 g

D
Environmental ScoreScore D
Green HostingNo
Download Digital Emissions AnalysisPowered by illuminem and Dedalo AI

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Hofseth BioCare's health supplement marketing claims about salmon-derived bioactive peptides lacked sufficient clinical evidence per Norwegian advertising standards.
Powered by illuminem

Market cap

5.7B $, 2026▼37% YoY

Revenue

24.6M $, FY2025▼0.4% YoY

EBITDA

0.0 $, FY2025▼9.1% YoY

Operating margin

NaN% Industry: -370▼NaN% YoY

Revenue & EBITDA

$24.6MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-1.3M 2024▲18.4% YoY

Capex

380.0K 2024▼250% YoY

Debt/equity ratio

-3.0 Industry: 2▼NaN% YoY

R&D intensity

4.7%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-88.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

2023

0.0

2024

0.0

2025

NaN


Powered by illuminem

Sustainability targets and commitments

TargetYearValueScopeBaseline

Progress against targets

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Available

Workplace health & safety policy

Available

18%
Independent Directors

2 out of 11 incl. management

Powered by illuminem

Overall score

74

Environment

83

Social

64

Governance

76

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees


Total sustainability employees

2-3


    Available in
    Scale package

    Access
  • Email

  • Email